Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04813185 · ClinicalTrials.gov registry record · NA

Preventing Retaliatory Gun Violence in Violently Injured Adults

A NA study of Violence, sponsored by Virginia Commonwealth University.

Recruiting
Registry status
NA
Development phase
616
Enrollment target
1
Study location

NCT04813185 is a NA study of Violence that is actively recruiting participants, run by Virginia Commonwealth University. The registered enrollment target is 616 participants, below the 4,505-participant average among 19 other Violence trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04813185, a NA study of Violence, is actively recruiting participants, sponsored by Virginia Commonwealth University.

RECRUITING
Registry status
NA
Development phase
616 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to find out if a hospital-based violence intervention (Bridging the Gap) is effective for reducing violence. The researchers think that adults who receive Bridging the Gap will see greater improvements than those who do not receive the intervention. This study will allow them to learn more about the intervention's effectiveness. The study will also help them understand if the violence intervention affects other behaviors, such as firearm use, drug use, aggression, risky behaviors, and rates of violent re-injury.

Conditions Studied

Interventions

  • BEHAVIORAL Bridging the Gap

Study Locations (1)

Virginia

  • Virginia Commonwealth University - Richmond

Trial Details

FieldValue
Enrollment Target 616 participants
Start Date 2021-07-27
Est. Completion 2026-12
Phase NA

Sponsor

Virginia Commonwealth University

558 total trials

What the Registry Record Tells You About NCT04813185

The ClinicalTrials.gov registry entry for NCT04813185 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 616 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,505-participant average among 19 other Violence trials with a reported enrollment target (86% lower). The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Violence appearing as the primary indexed condition, and to 1 intervention - of which Bridging the Gap is the first listed.

NCT04813185 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT04813185 about?

NCT04813185 is a clinical study titled "Preventing Retaliatory Gun Violence in Violently Injured Adults". The purpose of this research study is to find out if a hospital-based violence intervention (Bridging the Gap) is effective for reducing violence. The researchers think that adults who receive Bridging the Gap will see greater improvements than those who do not receive the intervention. This study w...

What is the current status of trial NCT04813185?

This trial is currently recruiting. It is a NA study. The enrollment target is 616 participants. The study started on 2021-07-27. Estimated completion is 2026-12.

What conditions does trial NCT04813185 study?

This clinical trial studies the following conditions: Violence.

What interventions are being tested in trial NCT04813185?

The interventions under investigation include: Bridging the Gap (BEHAVIORAL).

Who is sponsoring clinical trial NCT04813185?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04813185 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Violence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.